← back to search

Lin Wang

Shandong University · CN
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research focused on Cancer research and Lung cancer, with related work in Fusion gene, Cetuximab, Epidermal growth factor receptor. Notable publications include 'Lymph node metastasis in clinical stage IA peripheral lung cancer', 'Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm,...', and 'Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies'.
h-index
citations
342
works
8
NIH funding
primary concept
email

Recent publications

Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
Global Medical Genetics 2024cited by 14position: middledoi
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
Global Medical Genetics 2024cited by 7position: middledoi
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
The Lancet Respiratory Medicine 2023cited by 62position: middledoi
744MO AdvanTIG-202: Phase II randomized, multicenter, open-label study of tislelizumab (TIS) with or without ociperlimab (OCI) in patients (pts) with previously treated recurrent/metastatic (R/M) cervical cancer (CC)
Annals of Oncology 2023cited by 7position: middledoi
Chinese expert consensus on the diagnosis and treatment of <scp>HER2</scp>‐altered non–small cell lung cancer
Thoracic Cancer 2022cited by 17position: middledoi
Lymph node metastasis in clinical stage IA peripheral lung cancer
Lung Cancer 2015cited by 93position: firstdoi
Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies
Clinical Cancer Research 2015cited by 62position: middledoi
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
Oncogene 2015cited by 59position: middledoi
Benthic nutrient fluxes and limited denitrification in a sub-tropical groundwater-influenced coastal lagoon
Marine Ecology Progress Series 2014cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yan Zeng · University of Science and Technology of China2 papers (2015–2015)Jennifer R. Grandis · University of California, San Francisco2 papers (2015–2015)Jinwon Lee · Henry Ford Health System1 papers (2023–2023)June‐Yong Lee · New York University1 papers (2023–2023)Yu Shi · University of Virginia1 papers (2015–2015)Yunfeng Yuan · Sun Yat-sen University1 papers (2015–2015)Desheng Yao · Guangxi Medical University1 papers (2023–2023)H Li · Henry Ford Health System1 papers (2015–2015)Maria L. Freilino · University of Pittsburgh1 papers (2015–2015) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2015–2015) · 1 papers (2014–2014)Lina Wu · Wenzhou Medical University1 papers (2023–2023)W BURNETT · Florida State University1 papers (2014–2014)William E. Gooding · Cancer Research And Biostatistics1 papers (2015–2015) · 1 papers (2014–2014)John Winslow · LabCorp (United States)1 papers (2015–2015)Ahmed Chenna · LabCorp (United States)1 papers (2015–2015)Noah D. Peyser · University of California, San Francisco1 papers (2015–2015)